Koenig Sheldon L.
SEC insider (Form 3/4/5 filer). CIK 0001766524. President and CEO at Esperion Therapeutics, Inc. (ESPR). 11 reported Form 4/5 transactions since Sep 2024; latest on Jul 13, 2026. Located in ANN ARBOR, MI.
Companies Koenig Sheldon L. has filed insider reports for
- Esperion Therapeutics, Inc. (ESPR): Director, Officer, President and CEO
Koenig Sheldon L.
CIK: 0001766524
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Esperion Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jul 13, 2026ESPR
Esperion Therapeutics, Inc.
DispositionDirect2.1M shares- - Jun 17, 2026ESPR
Esperion Therapeutics, Inc.
SaleDirect53.6K shares at avg. $3.15$169K - Mar 17, 2026ESPR
Esperion Therapeutics, Inc.
SaleDirect25.6K shares at avg. $2.72$70K - Mar 13, 2026ESPR
Esperion Therapeutics, Inc.
AwardDirect723.8K shares- - Dec 17, 2025ESPR
Esperion Therapeutics, Inc.
SaleDirect48.2K shares at avg. $3.67$177K - Sep 17, 2025ESPR
Esperion Therapeutics, Inc.
SaleDirect28.4K shares at avg. $2.79$79K - Jun 17, 2025ESPR
Esperion Therapeutics, Inc.
SaleDirect30.5K shares at avg. $1.11$34K - Mar 18, 2025ESPR
Esperion Therapeutics, Inc.
SaleDirect13K shares at avg. $1.50$20K - Mar 14, 2025ESPR
Esperion Therapeutics, Inc.
AwardDirect840K shares- - Dec 17, 2024ESPR
Esperion Therapeutics, Inc.
SaleDirect12.4K shares at avg. $2.47$31K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 13, 2026 | ESPR Esperion Therapeutics, Inc. | Disposition | 2,121,094 | - | $0 | Direct |
| Jun 17, 2026 | ESPR Esperion Therapeutics, Inc. | Sale | 53,588 | $3.15 | $169,070 | Direct |
| Mar 17, 2026 | ESPR Esperion Therapeutics, Inc. | Sale | 25,578 | $2.72 | $69,547 | Direct |
| Mar 13, 2026 | ESPR Esperion Therapeutics, Inc. | Award | 723,760 | - | $0 | Direct |
| Dec 17, 2025 | ESPR Esperion Therapeutics, Inc. | Sale | 48,244 | $3.67 | $177,200 | Direct |
| Sep 17, 2025 | ESPR Esperion Therapeutics, Inc. | Sale | 28,427 | $2.79 | $79,254 | Direct |
| Jun 17, 2025 | ESPR Esperion Therapeutics, Inc. | Sale | 30,474 | $1.11 | $33,796 | Direct |
| Mar 18, 2025 | ESPR Esperion Therapeutics, Inc. | Sale | 13,047 | $1.50 | $19,623 | Direct |
| Mar 14, 2025 | ESPR Esperion Therapeutics, Inc. | Award | 840,000 | - | - | Direct |
| Dec 17, 2024 | ESPR Esperion Therapeutics, Inc. | Sale | 12,447 | $2.47 | $30,694 | Direct |
1-10 of 11 transactions